Situation
Pharma, Biotech and academia are constantly shifting their business models, seeking to access external innovation and enhance the value in medicinal products. Outdated R&D strategies are now being replaced by novel, more efficient approach to global clinical trials.
Target Audience
This is specifically true for small and mid-size sponsors which need to conduct global studies and do not have enough resources to manage multiple CROs and may not be able to afford global CRO services. In addition, such sponsors may lack the infrastructure, resources and expertise to manage their own international clinical trials.
Proposed Solution
ACROSS Global is an entirely new business model, providing enhanced and innovative global solutions through highly qualified, globally experienced, knowledgeable local experts. ACROSS Global identifies, analyses and mitigates risks across the entire clinical research spectrum, with an agility and focus to the envy of competitors. We provide value added solutions individually tailored for small and mid-size companies.
Solution
© Copyright 2024 ACROSS Global Alliance